COX6A2 and parasitic infectious disease: Although ivermectin is primarily used for treating parasitic infections, it has been identified as a mitochondrial ATP protector in CMs, enhancing mitochondrial ATP production in HL-1 CMs by upregulating the transcription of Cox6a2, a subunit of the mitochondrial respiratory chain [41].